Goldman Sachs questions whether curing patients is a sustainable business model

Re:Goldman Sachs questions whether curing patients is a sust... by saas_co_de on Friday April 13, 2018 @07:01AM (#16828791)

You are talking about providing health care. Not inventing new treatments. Those countries are all using treatments invented developed and funded by the market model which is mostly paid for by us consumers, which is part of why us prices are so high.

The US has the best outcomes in the world if you have money. Which is why rich people from all over the world come here for treatment. We just have lower average outcomes because of access disparities.

[ Parent | on HN ]

Re:Goldman Sachs questions whether curing patients is a sust... by Retric on Friday April 13, 2018 @07:04AM (#16828809)

[Citation Needed]

The US has average healthcare when money is no object. The weathty often seak treatment outside the US and occasionally wealthy people come to the US on a case by case basis.

The core problem is treatments entail risk, so doing more eventually results in worse outcomes. Further the incentives are around doing more, putting the healthcare system in opposition to heathy patients.

[ Parent | on HN ]

Re:Goldman Sachs questions whether curing patients is a sust... by TomK32 on Friday April 13, 2018 @07:36AM (#16828986)

Saldy when you are in need of healthcare, money is the only negotiation power you can have. An insurance company dealing for you has a lot more power, but if you are on your own you have no power to say "right, this vital heart op is too expensive, I'll drive 300 miles for a cheaper provider. ggrrrrl".

That's why universal healthcare is the better solution for everyone.

[ Parent | on HN ]